These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26946348)

  • 1. Alanine aminotransferase course, serum hepatitis B virus DNA, and liver stiffness measurement for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B.
    Charatcharoenwitthaya P; Phisalprapa P; Pausawasdi N; Rungkaew P; Kajornvuthidej S; Bandidniyamanon W; Chotiyaputta W; Chainuvati S; Tanwandee T
    Hepatol Res; 2016 Dec; 46(13):1347-1357. PubMed ID: 26946348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase.
    Wang D; Zhang P; Zhang M
    Exp Ther Med; 2017 Dec; 14(6):5363-5370. PubMed ID: 29285064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M; Sarin SK; Hissar S; Pande C; Sakhuja P; Sharma BC; Chauhan R; Bose S
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.
    Tan Y; Ye Y; Zhou X; Chen L; Wen D
    PLoS One; 2015; 10(4):e0123452. PubMed ID: 25885705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase.
    Chen L; Shi J; Lu Z; Ye Y; Zhou X; Tan Y
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):310-316. PubMed ID: 30528063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.
    Chen YC; Huang SF; Chu CM; Liaw YF
    J Viral Hepat; 2012 Feb; 19(2):138-46. PubMed ID: 22239503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Am J Gastroenterol; 2008 Dec; 103(12):3071-81. PubMed ID: 19086958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels.
    Yan JY; Li ZQ; Yu ZJ; Kan QC
    J Cell Biochem; 2019 Apr; 120(4):6632-6641. PubMed ID: 30368885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review.
    Papatheodoridis GV; Manolakopoulos S; Liaw YF; Lok A
    J Hepatol; 2012 Jul; 57(1):196-202. PubMed ID: 22450396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.
    Mbaye PS; Sarr A; Sire JM; Evra ML; Ba A; Daveiga J; Diallo A; Fall F; Chartier L; Simon F; Vray M
    PLoS One; 2011; 6(7):e22291. PubMed ID: 21799814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study.
    Zhang J; Du X; Zhou Z; Lv F; Yu Y
    J Int Med Res; 2019 Jan; 47(1):122-132. PubMed ID: 30213226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
    Nakazawa T; Shibuya A; Takeuchi A; Shibata Y; Hidaka H; Okuwaki Y; Takada J; Tanaka Y; Watanabe M; Minamino T; Sakurai K; Koizumi W
    J Viral Hepat; 2011 Jul; 18(7):e191-9. PubMed ID: 21692932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B.
    Gong X; Yang J; Tang J; Gu C; Huang L; Zheng Y; Liang H; Wang M; Wu C; Chen Y; Zhang M; Yu Z; Mao Q
    PLoS One; 2015; 10(7):e0134532. PubMed ID: 26230094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy.
    Guo H; Liao M; Jin J; Zeng J; Li S; Schroeder DR; Zheng J; Zheng R; Chen S
    Eur Radiol; 2020 Feb; 30(2):1096-1104. PubMed ID: 31673836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
    Xie Y; Yi W; Zhang L; Lu Y; Hao HX; Gao YJ; Ran CP; Lu HH; Chen QQ; Shen G; Wu SL; Chang M; Ping-Hu L; Liu RY; Sun L; Wan G; Li MH
    J Viral Hepat; 2019 Jul; 26 Suppl 1():42-49. PubMed ID: 31380591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.